Status:
COMPLETED
NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression
Lead Sponsor:
University Hospital Tuebingen
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this study (i) the host genome to identify susceptibility regions of infection, inflammation, and host defense, (ii) host response to Severe Acute Respiratory Syndrome-Corona-Virus-2 (SARS-CoV-2) i...
Detailed Description
This study aims to recruit adult persons with diagnostically confirmed Corona-Virus- Disease-19 (COVID-19) infection and with different disease manifestation who are included into diagnostic or therap...
Eligibility Criteria
Inclusion
- COVID-19 infection confirmed
- COVID-19 disease manifestation
- Age \> 18 years
Exclusion
- Missing informed consent of the patient/ legal guardian/ relatives
Key Trial Info
Start Date :
October 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04364828
Start Date
October 21 2020
End Date
August 31 2023
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Tübingen
Tübingen, Germany, 72076